About Stephen Quesenberry
Form D filings for Aspire BioPharma in 2023 list Stephen Quesenberry as executive officer and director.
Stephen Quesenberry first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Stephen Quesenberry in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Stephen Quesenberry works with at each company, as listed on that company's latest Form D.
Aspire BioPharma, Inc. · Form D, Nov 1, 2023
ES
Ernest Scheidemann
Executive officer and director
RP
Rodrick Prat
Director
KH
Kraig Higginson
President and CEO, director
EK
Edward Kimball
Director